Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute

Aida Ribera1,2, Ignacio Ferreira-Gonzalez1,2, Josep Ramon Marsal1,2

  • 1Cardiology Department, Vall d'Hebron University Hospital and Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.

BMJ Open
|July 26, 2019
PubMed

Insights

Dual antiplatelet therapy (DAPT) persistence increased after 2012 guidelines for ST-elevation acute coronary syndrome (STEACS) patients. A 12-month DAPT recommendation at discharge significantly improved adherence.

Area of Science:

  • Cardiology
  • Clinical Pharmacy
  • Health Services Research

Background:

  • Guidelines in 2012 recommended 12-month dual antiplatelet therapy (DAPT) for ST-elevation acute coronary syndrome (STEACS) patients post-percutaneous coronary intervention (PCI).
  • Understanding the impact of these guidelines on DAPT persistence is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To assess the trend in 12-month DAPT persistence from 2010-2015 following guideline implementation.
  • To evaluate the association between discharge DAPT recommendations and patient persistence.

Main Methods:

  • An observational study utilizing region-wide registry and pharmacy billing data.
  • Mixed-effects logistic regression models analyzed 10,711 STEACS patients undergoing PCI between 2010 and 2015.

Main Results:

  • 12-month DAPT persistence rose from 58% in 2010 to 73% in 2015.
  • Persistence significantly increased one year post-guideline publication (OR=1.20).
  • A 12-month DAPT recommendation at discharge strongly correlated with persistence (OR=5.76).

Conclusions:

  • 12-month DAPT persistence improved post-guideline implementation.
  • Guideline-based discharge recommendations are key drivers of DAPT adherence.
  • Standardizing prescribing criteria across hospitals can reduce variability and improve adherence.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
868
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
222
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
283
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
372
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
230
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
6.7K